Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Completed

Phase N/A Results N/A

Summary of Purpose

The present study will be conducted to assess the following research questions in real-life conditions in France: What are the patient and disease characteristics, comorbidities and treatment history in NVAF patients initiating a new Anticoagulant (AC) treatment, according to treatment currently available and prescribed (apixaban, other NOACs, VKAs), and are the AC-naive patient profiles different from one...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 April 2017.

1 Oct 2015 16 Mar 2016 1 Dec 2016 1 Dec 2016 1 Mar 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Cross-Sectional
  • Sampling: Probability Sample

Contacts

  • Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:

    Clinical.Trials@bms.com

  • First line of the email MUST contain NCT# and Site #.

  • For participation information at a USA site use a phone number below. For Site information outside USA please email:

    Clinical.Trials@bms.com